학술논문
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
Document Type
Article
Author
Gerds, A.T.; Verstovsek, S.; Vannucchi, A.M.; Al-Ali, H.K.; Lavie, D.; Kuykendall, A.T.; Grosicki, S.; Iurlo, A.; Goh, Y.T.; Lazaroiu, M.C.; Egyed, M.; Fox, M.L.; McLornan, D.; Harrison, C.N.; Perkins, A.; Yoon, S.-S.; Gupta, V.; Kiladjian, J.-J.; Granacher, N.; Lee, S.-E.; Ocroteala, L.; Passamonti, F.; Oh, S.; Klencke, B.J.; Donahue, R.; Kawashima, J.; Yu, J.; Mesa, R.
Source
In: The Lancet Haematology . (The Lancet Haematology, September 2023, 10(9):e735-e746)
Subject
Language
English
ISSN
23523026